Oncocyte acquires Chronix Biomedical to enter immune therapy monitoring market

Oncocyte Corporation has closed its previously announced acquisition of Chronix Biomedical, a US-based molecular diagnostics company that develops blood tests used in cancer treatment and ... Read More